Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Snelling

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
The European Respiratory Journal|October 9, 2025
Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohortParveen Fathima, Edward Pan, Julie Marsh, et al.
Vaccine|April 24, 2020
Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot studyJessica Kaufman, Katie Attwell, Jane Tuckerman, et al.
BMJ Open|November 16, 2019
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritisBianca Fleur Middleton, Mark A Jones, Claire S Waddington, et al.
BMJ Open Respiratory Research|October 8, 2021
Novel method to select meaningful outcomes for evaluation in clinical trialsCharlie McLeod, Richard Norman, Jamie Wood, et al.
Trials|June 16, 2026
ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutationsLorena Rodrigues Sabino, Gerard E Kaiko, Douglas Dorahy, et al.
Neurology|September 21, 2012
Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitalsGulam Khandaker, Yvonne Zurynski, Jim Buttery, et al.
Trials|July 17, 2024
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trialDavid W J Griffin, Michael Dymock, Germaine Wong, et al.
Journal of Medical Virology|October 11, 2021
Transplacental transfer of RSV antibody in Australian First Nations infantsNusrat Homaira, Michael Binks, Gregory Walker, et al.
Microbiome|November 27, 2021
Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxideLesley Hoyles, Matthew G Pontifex, Ildefonso Rodriguez-Ramiro, et al.
Nature Communications|June 15, 2026
Diagnostic challenges and Gram-negative pathogen dominance in early- and late-onset neonatal infection in Manila, PhilippinesMichelle L Harrison, Maria E Villanueva-Uy, Erena Kasahara, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The European Respiratory Journal|October 9, 2025
Characteristics, treatment and lung function outcomes of pulmonary exacerbations in cystic fibrosis: insights from the BEAT-CF cohortParveen Fathima, Edward Pan, Julie Marsh, et al.
Vaccine|April 24, 2020
Feasibility and acceptability of the multi-component P3-MumBubVax antenatal intervention to promote maternal and childhood vaccination: A pilot studyJessica Kaufman, Katie Attwell, Jane Tuckerman, et al.
BMJ Open|November 16, 2019
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritisBianca Fleur Middleton, Mark A Jones, Claire S Waddington, et al.
BMJ Open Respiratory Research|October 8, 2021
Novel method to select meaningful outcomes for evaluation in clinical trialsCharlie McLeod, Richard Norman, Jamie Wood, et al.
Trials|June 16, 2026
ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutationsLorena Rodrigues Sabino, Gerard E Kaiko, Douglas Dorahy, et al.
Neurology|September 21, 2012
Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitalsGulam Khandaker, Yvonne Zurynski, Jim Buttery, et al.
Trials|July 17, 2024
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trialDavid W J Griffin, Michael Dymock, Germaine Wong, et al.
Journal of Medical Virology|October 11, 2021
Transplacental transfer of RSV antibody in Australian First Nations infantsNusrat Homaira, Michael Binks, Gregory Walker, et al.
Microbiome|November 27, 2021
Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxideLesley Hoyles, Matthew G Pontifex, Ildefonso Rodriguez-Ramiro, et al.
Nature Communications|June 15, 2026
Diagnostic challenges and Gram-negative pathogen dominance in early- and late-onset neonatal infection in Manila, PhilippinesMichelle L Harrison, Maria E Villanueva-Uy, Erena Kasahara, et al.
Pageof 8